Article Figures & Data
Figures
- FIG 1
Screening of 1,493 men from a Milwaukee, WI, STI clinic, delineated by permutations of urine, pharyngeal, and rectal specimen collection.
- FIG 2
Transcription-mediated amplification detection rates of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium in 1,465 urine, 1,443 pharyngeal, and 823 rectal specimens. †, P < 0.0002 versus detection of other etiologies; ‡, P ≤ 0.002; *, not tested.
- FIG 3
Cumulative STI incidence rate, as a function of additional transcription-mediated amplification assays. †, P < 0.0002 versus combined Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis screening.
- FIG 4
Cumulative STI (open bars) and Mycoplasma genitalium (solid bars) incidence rates, as function of additional specimen source analysis. *, P ≤ 0.001 versus single- or double-collection paradigms; †, P = 0.02 versus urine M. genitalium screening.
